TickerFacts.

Electromedical Technologies, Inc (EMED): R&D Expense

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$231.4K
Year ended 2023-12-31
+94.2%
3-year compound annual growth
2019-12-31: $82.8K2020-12-31: $31.6K2021-12-31: $215.3K2022-12-31: $92.3K2023-12-31: $231.4K$231.4K
2019-12-31 R&D Expense (USD) 2023-12-31
Period endedR&D ExpenseChange YoYSource filing
2023-12-31$231.4K+150.7%2024-05-01, From 2023-01-01
2022-12-31$92.3K-57.1%2024-05-01, From 2022-01-01
2021-12-31$215.3K+581.4%2023-03-31, From 2021-01-01
2020-12-31$31.6K-61.9%2022-03-31, From 2020-01-01
2019-12-31$82.8Kn/a2021-03-30, From 2019-01-01